Novasep increases management structure
Novasep (Pompey, France) has announced the appointment of two managerial roles.
Novasep (Pompey, France) has announced the appointment of two managerial roles. Jean-Claude Romain has been named as the group’s newly-created corporate quality director and a member of Novasep’s executive committee, and Alain Lamproye has joined Novasep Process as director of Novasep Belgium and a member of Novasep’s process management committee.
Jean-Claude Romain has experience of quality and industrial production management, which he attained at several international pharmaceutical companies.
Alain Lamproye has held several site management and production management positions and has taken over the management of Novasep’s two Belgian sites. He will head a team of more than 100 staff specializing in custom biopharmaceutical manufacturing.
Roger-Marc Nicoud, chairman of Novasep, said, “We are delighted with the appointment of Jean-Claude Romain as corporate quality director of Novasep. His excellent work at Novasep Process has enabled us to continue developing our biopharmaceutical production activities. He is now going to use his experience and dynamism to improve quality control and lead the continuous improvement programme at all our sites.”
Antoine Baule, president of Novasep Process, commented, “The recognized experience of Alain Lamproye represents a real added value for Novasep Belgium. In a fast-growing biopharmaceutical market, custom biopharmaceutical manufacturing is a strategic activity for Novasep, which we will actively continue to develop.”
For more information please visit ref="http://www.novasep.com">www.novasep.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
